Role of Polo-Like Kinase-1 in Melanocytic Transformation

Grants and Contracts Details


In this grant, the Liu laboratory will perform the experiments proposed in Aims 2 and 3. Specifically, to establish that Plk1 and B-Raf are two synthetic lethal partners in vitro, the Liu laboratory will determine whether melanoma cells harboring the B-Raf-V600E mutation have higher mitotic indices than cells with wild type B-Raf, analyze whether the B-Raf-V600E mutation enhances sensitivity of cellular response to mitotic stress, and ask whether melanoma cells with the B-Raf-V600E mutation are hypersensitive to inhibition/depletion of Plk1 than cells with wild type B-Raf. With extensive experience with Plk1 in basic cell biology, the Liu laboratory will finish the proposed experiments within four years.
Effective start/end date1/1/194/30/20


  • University of Wisconsin: $127,492.00


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.